Safety and vasopressor effect of rosuvastatin in septic patientsFootnote

Available online 19 March 2014

References

• C.C.McGownZ.L.S.BrookesBeneficial effects of statins on the microcirculation during sepsis: the role of nitric oxideBr J Anaesth982007163175
   PubMed Web of Science ®Google Scholar
• B.B.TanR.L.PrewittL.D.BrittInterleukin-10 prevents loss of rat skeletal muscle arterioles exposed to endotoxinJ Surg Res1002001110115
   Web of Science ®Google Scholar
• J.L.VincentCardiovascular alterations in septic shockJ Antimicrob Chemother411998915
   Web of Science ®Google Scholar
• R.J.BealeS.M.HollenbergJ.L.VincentJ.E.ParrilloVasopressor and inotropic support in septic shock: an evidence based reviewCrit Care Med3211 suppl.2004S455S465
   PubMedGoogle Scholar
• D.PrueferJ.MakowskiM.SchnellU.BuerkeM.DahmH.OelertSimvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxinCirculation106200221042110
   PubMed Web of Science ®Google Scholar
• Y.RikitakeS.KawashimaS.TakeshitaT.YamashitaH.AzumiM.YasuharaAnti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbitsAtherosclerosis15420018796
   PubMed Web of Science ®Google Scholar
• R.C.BoneR.A.BalkF.B.CerraACCP/SCCM consensus conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsisCrit Care Med201992964974
   Web of Science ®Google Scholar
• X.ViviandM.LeoneX.ThirionEffect of norepinephrine on the outcome of septic shockCrit Care Med2882000
   Web of Science ®Google Scholar
• T.M.GlembotL.D.BrittM.A.HillLack of direct endotoxin induced vasoactive effects on isolated skeletal muscle arteriolesShock31995216223
   Web of Science ®Google Scholar
• T.M.GlembotL.D.BrittM.A.HillEndotoxin interacts with tumour necrosis factor-alpha to induce vasodilation of isolated rat skeletal muscle arteriolesShock51996251257
   Web of Science ®Google Scholar
• R.ScaliaT.J.StalkerMicrocirculation as a target for the anti-inflammatory properties of statinsMicrocirculation92002431442
   Web of Science ®Google Scholar
• P.A.VoB.LadJ.A.TomlinsonS.FrancisA.AhluwaliaAutoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and functionJ Biol Chem280200572367243
   PubMed Web of Science ®Google Scholar
• T.YamashitaS.KawashimaY.OhashiResistance to endotoxin shock in transgenic mice over expressing endothelial nitric oxide synthaseCirculation1012000931937
   Web of Science ®Google Scholar
• U.LaufsV.L.FataJ.K.LiaoInhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia mediated down-regulation of endothelial nitric oxide synthaseJ Biol Chem27219973172531729
   PubMed Web of Science ®Google Scholar
• U.LaufsV.La FataJ.PlutzkyJ.K.LiaoUpregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitorsCirculation97199811291135
   PubMed Web of Science ®Google Scholar
• U.LaufsK.GertzU.DirnaglM.BohmG.NickenigM.EndresRosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in miceBrain Res94220022330
   PubMed Web of Science ®Google Scholar
• MarsikPolterauerStefanKapiotisStylianosPleiner Michael WolztJohannesSchallerGeorgMittermayerFriedrichSimvastatin prevents vascular hyporeactivity during inflammationCirculation110200433493354
   Web of Science ®Google Scholar
• A.Giusti-PaivaM.R.MartinezJ.V.FelixSimvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in ratsShock212004271275
   PubMed Web of Science ®Google Scholar
• C.C.McGownN.J.BrownP.G.HellewellBeneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase IIIBr J Anaesth10422010183190
   Web of Science ®Google Scholar
• Almog Y, shefer A, Novack V, et al. Prior statin therapy protects against severe sepsis. Presented at: annual meeting of the Society of Critical Care Medicine; Orlando, Fla Circulation 2004; 110(7): 880–5.
   Google Scholar
• DosonChuaKarinaChoiceRochelleGellatlyGlenBrownStatin use and morbidity outcomes in septic shock patients: a retrospective cohort studyCrit Care Shock1420111518
   Google Scholar
• P.KrugerM.BaileyR.BellomoD.J.CooperM.HarwardA.HigginsA multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsisAm J Respir Crit Care Med1877201374375010.1164/rccm.201209-1718OC
   PubMed Web of Science ®Google Scholar
• E.RiversB.NguyenS.HavstadEarly goal- directed therapy collaborative group. Early goal-directed therapy in the treatment of severe sepsis and septic shockN Engl J Med34519200113681377
   PubMed Web of Science ®Google Scholar
• B.M.FullerM.GajeraC.SchorrThe association of prior statin use in septic shock treated with early goal directed therapyEur J Emerg Med1942012226230
   Web of Science ®Google Scholar
• R.FernandezV.J.De PedroA.ArtigasStatin therapy prior to ICU admission: protection against infection or a severity marker?Intens Care Med322006160164
   PubMed Web of Science ®Google Scholar
• E.M.MortensenM.I.RestrepoL.A.CopelandImpact on previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsisPharmacotherapy2712200716191626
   Web of Science ®Google Scholar
• M.W.DonninoM.N.CocchiM.HowellStatin therapy is associated with decreased mortality in patients with infectionAcad Emerg Med162009230234
   PubMed Web of Science ®Google Scholar
• M.J.TerblancheR.PintoC.WhiteleyStatins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort studyCrit Care151201174
   Web of Science ®Google Scholar
• L.J.HarrisR.ThapaM.BrownClinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgiaJ Clin Lipidol542011299307
   Web of Science ®Google Scholar